Alleviation of Neuropathic Pain by Intrathecal Injection of Antisense Oligonucleotides to P65 Subunit of Nf-Kappa B

T. Sun,W. -G. Song,Z. -J. Fu,Z. -H. Liu,Y. -M. Liu,S. -L. Yao

DOI: https://doi.org/10.1093/bja/ael209

IF: 11.719

2006-01-01

British Journal of Anaesthesia

Abstract:Background. Treatment of neuropathic pain remains a challenge. The current study investigated the therapeutic effect of intrathecal administration of NF-kappa B antisense oligodeoxynucleotides (ODNs) on mechanical allodynia and thermal hyperalgesia in a chronic constriction injury (CCI) model of rats.Methods. Lumbar intrathecal catheters were implanted in male Sprague-Dawley rats and a CCI model was established. Thermal and mechanical nociceptive thresholds were assessed with paw withdrawal latency (PWL) to radiant heat and von Frey filaments. The phosphorothioate-modified antisense ODNs to p65 subunit of NF-kappa B were administered intrathecally on each of five consecutive days post-CCI. Nuclear NF-kappa B p65 expression was assessed by western blot.Results. CCI induced mechanical allodynia and thermal hyperalgesia and significantly increased NF-kappa B p65 protein expression. Intrathecal injection of antisense ODN markedly suppressed the expression of NF-kappa B p65 protein and significantly attenuated CCI-induced mechanical allodynia and thermal hyperalgesia.Conclusion. The activation of NF-kappa B pathway may contribute to neuropathic pain in CCI rats. Suppression of NF-kappa B could be a potential new strategy for the treatment of neuropathic pain.